DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Heterocyclic ScaffoldsHeterocyclic Scaffolds
  5. /ImidazolidinesImidazolidines
  6. /Methanesulfonamide, N-(2-((2R,12bs)-1,3,4,6,7,12b-hexahydro-2'-oxospiro(2H-benzofuro(2,3-a)quinolizine-2,4'-imidazolidin)-3'-yl)ethyl)-, hydrochloride (1:1)CAS 130466-38-5
Chemical structure of CAS 130466-38-5

Methanesulfonamide, N-(2-((2R,12bs)-1,3,4,6,7,12b-hexahydro-2'-oxospiro(2H-benzofuro(2,3-a)quinolizine-2,4'-imidazolidin)-3'-yl)ethyl)-, hydrochloride (1:1)

In Stock•Starting at $1121 for 1 mg•Purity ≥ 99.89%
CAS No.130466-38-5
MDL No.N/A
MFC20H27ClN4O4S
MW455.00
InChI KeyUTMOWVIYZQWJHT-VASSOYJASA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg99.89%$1121In Stock
5 mg99.89%$2788In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.130466-38-5
Product NameMethanesulfonamide, N-(2-((2R,12bs)-1,3,4,6,7,12b-hexahydro-2'-oxospiro(2H-benzofuro(2,3-a)quinolizine-2,4'-imidazolidin)-3'-yl)ethyl)-, hydrochloride (1:1)
Heavy Atom Count30Rotatable Bond Count4
Atom Stereo Count2Bond Stereo Count0
HBA5HBD2
TPSA94.890 ŲCharge0
Exact Mass454.14415Complexity1071.94
pKa5.875XLogP1.861

Documentation

Similar Products

  • Orm-12741

    CAS No.610782-82-6

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact